SpectraWAVE provides optical and computational insights to improve treatment for coronary artery disease patients. $50M Series B led by Johnson and Johnson, with participation from S3 Ventures, Lumira Ventures, SV Health, and Deerfield.
SpectraWAVE Announces $50M Series B Financing
Previous
Previous
Prokeep Secures $25M Series A
Next
Next